Monitoring the progression of metastatic breast cancer on nanoporous silica chips

Breast cancer accounted for 15 per cent of total cancer deaths in female patients in 2010. Although significant progress has been made in treating early-stage breast cancer patients, there is still no effective therapy targeting late-stage metastatic breast cancers except for the conventional chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Jia, Deng, Xiaoyong, Gallagher, James W., Huang, Haiyu, Huang, Yi, Wen, Jianguo, Ferrari, Mauro, Shen, Haifa, Hu, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society Publishing 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318679/
https://www.ncbi.nlm.nih.gov/pubmed/22509065
http://dx.doi.org/10.1098/rsta.2011.0444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318679/
https://www.ncbi.nlm.nih.gov/pubmed/22509065
http://dx.doi.org/10.1098/rsta.2011.0444

Ejemplares similares